VW Reaches $15 billion Emissions Settlement

By Sophie Williams –

Volkswagen initially encountered up to $18 billion in fines for violating the U.S. Clean Air Act. VW sold over 11 million cars worldwide with deceptive software that cut back on cars’ emissions while undergoing tests.

Read more here…

URL: http://www.wsj.com/articles/volkswagen-to-pay-up-to-14-7-billion-to-settle-diesel-emissions-claims-1467117548

Actos Settlement Reached

It was announced Saturday that the $2.4 billion Actos settlement agreement reached on April 28, 2015 is final. The finalization of this settlement with Takeda will benefit just over 10,000 persons claiming injury from its diabetes drug, Actos. Plaintiffs will now be required to submit medical proof of their injury and use, while the settlement administrators review claims packages and approve awards. If you are a client of The Nations Law Firm, we may be reaching out to you in the near future so be looking for any correspondence from us. This is great news for all of our Actos clients!

Opt-In Extensions for Actos (and Potential Delays)

By Buck Daniel

After the proposed Actos settlement was opened for plaintiffs to opt-in, several extensions have been granted that allow opt-in decisions until September 11th. There has been much talk about the reasons for these extensions, but nothing has been confirmed. If we feel that the reasons behind these extensions put the settlement in jeopardy, we will inform our clients immediately. However at this point in time, although there has been a delay in this portion of the settlement and subsequently the date for submission for the settlement administrator’s review, we still expect compensation funds to be available by summer 2016. We urge any of our clients with specific questions about the status of this settlement to contact our office.

HIP IMPLANTS – An End of Year Update

By Kim Truongle –

ASR – We are pleased to report that all of our clients who elected to participate in the U.S. ASR Settlement earlier this year have been funded the majority of their claim.  We currently await the Settlement Administrator’s review of bonus claims out of the Extraordinary Injury Fund, and it is anticipated that this review will take several more months, due to the number of claims submitted nationwide.  For clients whose ASR hip has not yet been revised, we are working to comply with the Judge’s recent Order to take action to dismiss (yet preserve) claims, or move forward with limited case-specific discovery.  If you are one of our ASR clients and have not been contacted by us in recent months, it is important that you contact us immediately at (800) 269-3050, as your contact information is likely outdated.

Pinnacle – The Pinnacle litigation is, as expected, moving at a slower pace than the ASR litigation.  The first Pinnacle MDL trial occurred this year, and unfortunately, the verdict was handed down in the Defendant’s favor.  We are keeping an eye on further developments in this litigation.

Other Manufacturers – We are also working on hip cases manufactured by Biomet, Wright Medical, and Zimmer, though these make up a much smaller percentage of our docket.  If you have one of those cases with us, please feel free to phone our office for an update on your specific case.

Case-Specific Updates – Due to the unique nature of these claims, our office usually does not proactively contact you unless a major development has occurred in your case.  Otherwise, our time would be spent just updating clients, instead of working on the case itself.  Not hearing from us does not mean that your case is idle, nor does it mean that you are not represented.  Instead, we have an “open door” policy that anytime you would like an update, simply phone us at (800) 269-3050 to speak to a Case Manager.  If one is unavailable due to the volume of calls, you will receive a callback within 1 business day.  Instead of generic updates done in a mass mailout, we think this method better keeps you updated on YOUR specific case, and it also works better to fit into your busy schedule.

We are moving forward on our hip cases and hope to be able to report a positive outcome for our clients.

Happy Holidays to you and yours as we look forward to 2015!

Pradaxa Settlement

By Buck Daniel

May 29, 2014 – The Nations Law Firm is pleased to announce the settlement of all of its Pradaxa claims against Boehringer Ingelheim. The pharmaceutical company will pay $650 million to settle all 4,000 state and federal lawsuits over its blood thinner Pradaxa (dabigatran). In 2011 alone, more than 540 patients lost their lives after using Pradaxa, according to FDA reports, and thousands of people reported serious side effects — surpassing all other monitored drugs for the year.

“Today’s settlement will bring justice and financial assistance to those hurt while taking Pradaxa,” a member of the Plaintiffs’ Steering Committee, said in a statement. “We are proud of the settlement we have achieved, congratulate the company on doing the right thing, and look forward to distributing these funds to our clients as expeditiously as possible.”

ASR PROPOSED SETTLEMENT – Preliminary Info

By Howard Nations –

November 20, 2013 – Recent activity in the DePuy ASR litigation increases the possibility of a settlement for ASR users who were required to have a revision or replacement of their implanted ASR hip device. Let me be clear up front that this is the beginning of a proposed settlement and we are still a long way from the end.

On November 19, 2013 at a conference in the Ohio federal court where the ASR litigation is pending , Johnson and Johnson  and the Plaintiff’s Steering Committee announced preliminary information regarding a proposed global settlement, limited to ASR hip cases which involve a revision.  At this time, the detailed information has not been finalized and there is a lot of misinformation in the press that is based on leaks and speculation, most of which is inaccurate. There is no set amount offered as a settlement for each case. Instead, there is a very complicated formula which is based on individual case facts and on what evidence each Plaintiff can offer which will determine the final value of each proposed settlement offer from Johnson and Johnson.

This is a PROPOSED settlement rather than a completed settlement because Johnson and Johnson has the right to refuse to proceed with the settlement unless 94% of the potential claimants agree to the global settlement terms.

There remains a lot of work in this case and this proposal for a global settlement will not generate any settlement funds to any Plaintiff before the Summer of 2014, at the earliest. It could be much later that that. There is also the possibility that the entire proposed settlement may collapse if it is not supported by a sufficient number of Plaintiffs.

There are numerous elements that will be considered before qualification and amounts of settlement can be determined.  Once specific qualification criteria and details regarding this proposed settlement are available, we will contact our clients individually to discuss their options. For those of you who do not have a revision, we will  evaluate your alternatives with you also.

It is our policy to review the proposed settlement individually, as it applies to each of our clients and assist each client with a personal evaluation of the precise bottom line for you, if you choose to participate in this settlement. As soon as the details of the settlement proposal are finalized to the point that we can help you make an intelligent evaluation as to the alternatives that are available to you, we will contact you and begin the evaluation process.

Thanks for your patience.